Medartis announces completion of a CHF 30 million capital increase to finance its additional stake in Keri Medical
Medartis Holding AG / Key word(s): Capital Increase
Release of an ad hoc announcement pursuant to Art. 53 LR. The issuer is solely responsible for the content of this announcement.
Basel, 17 March 2023: Medartis Holding AG (SIX: MED), an orthopaedic company specialising in head and extremity surgery, today announced the successful completion of a small capital increase of CHF 30 million in a private placement to finance an additional stake in Keri Medical SA and for general corporate purposes.
As part of its growth strategy, Medartis announced at the publication of its 2022 annual results on Tuesday that it had signed an agreement to increase its stake in Keri Medical SA to 47% through the purchase of an additional 18% stake for approximately CHF 18 million. 476,190 newly issued shares, representing 4% of the total share capital, were sold in a private placement to a selected number of institutional investors.
Dirk Kirsten, CFO Medartis, comments: “Following the publication of our 2022 annual results, we received positive signals from investors and shareholders. We decided to take advantage of this opportunity to expand the free float of our share.”
These shares will be traded on the SIX Swiss Exchange from 23 March 2023. The new shares were issued from existing authorised capital at a price of CHF 63.00 per share each, which represents a discount of 4.7% to volume weighted average price of the Medartis shares on 14 and 15 March 2023.
Medartis Holding AG
Telephone: +41 61 633 37 36
Disclaimer and forward-looking statements
End of Inside Information
|Company:||Medartis Holding AG|
|Phone:||+41 61 633 34 34|
|Fax:||+41 61 633 34 00|
|Listed:||SIX Swiss Exchange|
|EQS News ID:||1585023|
|End of Announcement||EQS News Service|